We recently interviewed cancer researcher Tim Triche from Children's Hospital Los Angeles. Tim had two main points: First, microarrays are still a very valuable tool for research and for the clinic. Second, there are perhaps more answers for cancer research to be found in the non-coding portion of the genome than in the genes.
Here, we've compiled Tim's comments on the staying power of arrays.
Editor's Note: In this interview, Tim refers to an older generation Affymetrix array (GeneChip(R) Exon 1.0 ST Array). The newest array (GeneChip(R) Human Transcriptome Array 2.0) is able to measure gene and exon level expression of coding and long non-coding RNA with the ability to detect alternative splicing events.